Skip to main content

Table 5 Discriminatory performance of procalcitonin for detection of bacterial pneumonia a

From: Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis

 

Cutoff

Sensitivity, % (95% CI)

Specificity, % (95% CI)

Positive PV, % (95% CI)

Negative PV, % (95% CI)

Positive likelihood ratio (95% CI)

Negative likelihood ratio, % (95% CI)

Total

>0.25 μg/L

87.0 (77.4 to 93.6)

28.6 (19.2 to 39.5)

52.8 (43.7 to 61.7)

70.6 (52.5 to 84.9)

1.22 (1.04 to 1.43)

0.45 (0.23 to 0.89)

 

>0.5 μg/L

80.5 (69.9 to 88.7)

48.8 (37.7 to 60.0)

59.1 (49.0 to 68.6)

73.2 (59.7 to 84.2)

1.57 (1.24 to 1.99)

0.40 (0.24 to 0.66)

 

>1 μg/L

71.4 (60.0 to 81 to 2)

59.5 (48.3 to 70.1)

61.8 (50.9 to 71.9)

69.4 (57.5 to 79.8)

1.76 (1.31 to 2.37)

0.48 (0.32 to 0.71)

Without hospital-acquired pneumonia or immune-compromising disorder

>0.25 μg/L

90.9 (80.1 to 97.0)

31.9 (21.2 to 44.2)

51.6 (41.2 to 61.8)

81.5 (61.9 to 93.7)

1.33 (1.11 to 1.60)

0.29 (0.12 to 0.70)

 

>0.5 μg/L

85.5 (73.3 to 93.5)

53.6 (41.2 to 65.7)

59.5 (47.9 to 70.4)

82.2 (68.0 to 92.0)

1.84 (1.40 to 2.43)

0.27 (0.14 to 0.53)

 

>1 μg/L

74.6 (61.0 to 86.3)

60.9 (48.4 to 72.4)

60.3 (47.7 to 72.0)

75.0 (61.6 to 85.6)

1.91 (1.37 to 2.66)

0.42 (0.26 to 0.68)

  1. aCI, Confidence interval; PV, Predictive value.